Skip to main content

Table 4 Tumor metabolites with fold changes and t-test p-values in carbohydrate vs fasting groups

From: Metabolic consequences of perioperative oral carbohydrates in breast cancer patients — an explorative study

Tumor metabolite

P (All)a

FC (All)

P (ER+)b

FC (ER+)

Acetate

0.844

-1.030

0.620

-1.095

Alanine

0.322

1.038

0.163

1.067

Ascorbate

0.300

-1.099

0.991

-1.001

Aspartate

0.385

1.100

0.545

1.088

Choline

0.136

1.056

0.547

1.027

Creatine

0.418

-1.062

0.558

-1.051

Glucose

0.495

-1.151

0.500

-1.201

Glutamate

0.172

1.047

0.146

1.055

Glutamine

0.955

1.003

0.816

-1.015

Glutathione

0.006

1.082

0.002

1.103

Glycerophosphocholine

0.712

-1.018

0.762

-1.018

Glycine

0.186

1.063

0.162

1.090

Lactate

0.862

1.006

0.922

1.004

Leucine

1.000

1.000

0.947

-1.004

Myoinositol

0.445

-1.038

0.768

-1.018

Phosphocholine

0.517

1.027

0.291

1.051

Phosphoethanolamine

0.211

1.050

0.544

1.031

Scylloinositol

0.926

-1.007

0.565

1.060

Succinate

0.788

1.022

0.503

1.067

Taurine

0.982

1.001

0.902

1.004

  1. Abbreviations: ER+ Estrogen receptor positive, FC Fold change, P T-test p-value
  2. aSignificant at p ≤ 0.001 after Benjamini-Hochberg correction
  3. bSignificant at p ≤0.030 after Benjamini-Hochberg correction